Tytuł pozycji:
SAFETY AND RESPONSE AFTER 2 CYCLES OF BRENTUXIMAB VEDOTIN SUBSTITUTING VINCRISTINE IN THE OEPA/COPDAC REGIMEN FOR HIGH RISK PEDIATRIC HODGKIN LYMPHOMA (HL).
-
Tytuł:
-
SAFETY AND RESPONSE AFTER 2 CYCLES OF BRENTUXIMAB VEDOTIN SUBSTITUTING VINCRISTINE IN THE OEPA/COPDAC REGIMEN FOR HIGH RISK PEDIATRIC HODGKIN LYMPHOMA (HL).
-
Autorzy:
-
Metzger, M.
Mauz‐Körholz, C.
Flerlage, J.
Bartelt, J.
Billett, A.
Choi, J.K.
Ehrhardt, M.
Georgi, T.
Hasenclever, D.
Wang, F.
Zhang, H.
Kaste, S.C.
Kluge, R.
Körholz, D.
Kurch, L.
Link, M.
Stoevesandt, D.
Hudson, M.M.
Krasin, M.
-
Temat:
-
HODGKIN'S disease
VINCRISTINE
PROGRESSION-free survival
-
Źródło:
-
Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p55-56, 2p
-